Annual Total Liabilities
$264.74 M
+$14.96 M+5.99%
December 31, 2023
Summary
- As of February 7, 2025, ATRA annual total liabilities is $264.74 million, with the most recent change of +$14.96 million (+5.99%) on December 31, 2023.
- During the last 3 years, ATRA annual total liabilities has risen by +$138.95 million (+110.47%).
- ATRA annual total liabilities is now at all-time high.
Performance
ATRA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$233.25 M
+$5.09 M+2.23%
September 30, 2024
Summary
- As of February 7, 2025, ATRA quarterly total liabilities is $233.25 million, with the most recent change of +$5.09 million (+2.23%) on September 30, 2024.
- Over the past year, ATRA quarterly total liabilities has dropped by -$31.49 million (-11.89%).
- ATRA quarterly total liabilities is now -11.89% below its all-time high of $264.74 million, reached on December 31, 2023.
Performance
ATRA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ATRA Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.0% | -11.9% |
3 y3 years | +110.5% | -2.4% |
5 y5 years | +399.7% | -2.4% |
ATRA Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +40.4% | -11.9% | +34.9% |
5 y | 5-year | at high | +407.5% | -11.9% | +399.2% |
alltime | all time | at high | +8904.6% | -11.9% | >+9999.0% |
Atara Biotherapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $233.25 M(+2.2%) |
Jun 2024 | - | $228.15 M(-13.4%) |
Mar 2024 | - | $263.58 M(-0.4%) |
Dec 2023 | $264.74 M(+6.0%) | $264.74 M(+10.5%) |
Sep 2023 | - | $239.63 M(+0.3%) |
Jun 2023 | - | $238.99 M(+0.8%) |
Mar 2023 | - | $237.12 M(-5.1%) |
Dec 2022 | $249.78 M(+32.5%) | $249.78 M(+37.8%) |
Sep 2022 | - | $181.20 M(+1.4%) |
Jun 2022 | - | $178.64 M(+3.3%) |
Mar 2022 | - | $172.96 M(-8.2%) |
Dec 2021 | $188.51 M(+49.9%) | $188.51 M(+34.9%) |
Sep 2021 | - | $139.78 M(+11.6%) |
Jun 2021 | - | $125.25 M(-4.1%) |
Mar 2021 | - | $130.60 M(+3.8%) |
Dec 2020 | $125.78 M(+141.1%) | $125.78 M(+143.8%) |
Sep 2020 | - | $51.60 M(+9.8%) |
Jun 2020 | - | $46.99 M(+0.6%) |
Mar 2020 | - | $46.73 M(-10.4%) |
Dec 2019 | $52.16 M | $52.16 M(+12.6%) |
Sep 2019 | - | $46.34 M(+10.7%) |
Jun 2019 | - | $41.87 M(+2.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $40.79 M(-23.0%) |
Dec 2018 | $52.98 M(+32.7%) | $52.98 M(+32.8%) |
Sep 2018 | - | $39.89 M(-0.8%) |
Jun 2018 | - | $40.21 M(+18.5%) |
Mar 2018 | - | $33.92 M(-15.0%) |
Dec 2017 | $39.91 M(+292.2%) | $39.91 M(+68.2%) |
Sep 2017 | - | $23.74 M(+3.2%) |
Jun 2017 | - | $23.01 M(+167.4%) |
Mar 2017 | - | $8.60 M(-15.5%) |
Dec 2016 | $10.18 M(+3.1%) | $10.18 M(-28.4%) |
Sep 2016 | - | $14.21 M(+34.5%) |
Jun 2016 | - | $10.57 M(+15.6%) |
Mar 2016 | - | $9.14 M(-7.4%) |
Dec 2015 | $9.88 M(+235.9%) | $9.88 M(+48.9%) |
Sep 2015 | - | $6.63 M(-44.0%) |
Jun 2015 | - | $11.85 M(+218.2%) |
Mar 2015 | - | $3.72 M(+26.6%) |
Dec 2014 | $2.94 M(-95.3%) | $2.94 M(-96.2%) |
Sep 2014 | - | $77.15 M(+3283.7%) |
Jun 2014 | - | $2.28 M(-97.1%) |
Mar 2014 | - | $77.57 M(+23.4%) |
Dec 2013 | $62.84 M(+683.9%) | $62.84 M |
Dec 2012 | $8.02 M | - |
FAQ
- What is Atara Biotherapeutics annual total liabilities?
- What is the all time high annual total liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual total liabilities year-on-year change?
- What is Atara Biotherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly total liabilities year-on-year change?
What is Atara Biotherapeutics annual total liabilities?
The current annual total liabilities of ATRA is $264.74 M
What is the all time high annual total liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual total liabilities is $264.74 M
What is Atara Biotherapeutics annual total liabilities year-on-year change?
Over the past year, ATRA annual total liabilities has changed by +$14.96 M (+5.99%)
What is Atara Biotherapeutics quarterly total liabilities?
The current quarterly total liabilities of ATRA is $233.25 M
What is the all time high quarterly total liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly total liabilities is $264.74 M
What is Atara Biotherapeutics quarterly total liabilities year-on-year change?
Over the past year, ATRA quarterly total liabilities has changed by -$31.49 M (-11.89%)